Prosecution Insights
Last updated: October 25, 2026

Pa - Bozicevic Field & Francis LLP

Technology area: Biotechnology & Pharmaceuticals

109 pending office actions • 73 clients • 102 examiners • 71 art units • 0 of 109 (0%) have an AI response strategy ready

Analysis

PA - BOZICEVIC FIELD & FRANCIS LLP handles Biotechnology & Pharmaceuticals matters with 8,797 career applications. Its portfolio has 106 pending office actions, indicating an active prosecution docket that may require ongoing review and response planning.

The resolved allowance rate is 75.76%, while allowed matters receive an average of 3.96 office actions per allowance. Practitioners evaluating this record can focus on amendment strategy, response timing, and the amount of prosecution activity associated with applications that ultimately proceed to allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=8797 apps, methodology: how we score firms)

75.8%
Allowance Rate
n=8797
+0.66σ
Allowance Rate (norm)
n=8797
4.0
OAs to Allowance
n=4212
+0.02σ
OAs to Allow (norm)
n=4212
1094 days
Time to Allowance
n=4212
+22.0pp
Interview Lift
n=8797
28.4%
RCE Rate
n=8797
2.8%
Appeal Rate
n=8797

Rejection Performance (% of received rejections ultimately overcome)

74.9%
§101 Overcome
n=696
74.8%
§102 Overcome
n=2037
74.6%
§103 Overcome
n=3154
75.8%
§112 Overcome
n=3075

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
32%
Top-3 CPC Share
n=8797
20
Practitioners
n=8797
439.8
Apps / Practitioner
n=8797

Portfolio Summary

109
Total Pending OAs
69
Non-Final OAs
37
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 35 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
3
Due this week
10
Due this month
5
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 35 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 7 days (3)Due ≤ 30 days (10)Due ≤ 60 days (5)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

61
Hard (56%)
37
Medium (34%)
11
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other16 (15%)
§103 only22 (20%)
§102 only4 (4%)
§112 only9 (8%)
Double-patenting only2 (2%)
Double-patenting + other11 (10%)
Multi-statute (no §101)45 (41%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

81
Life Sciences
74% of docket
5
Information Tech
5% of docket
3
Communications
3% of docket
1
Semiconductors
1% of docket
17
Mechanical / Eng
16% of docket
2
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,090 h
Manual time on pending OAs
218 h
Time saved (low, 20%)
382 h
Time saved (mid, 35%)
9.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LU, FRANK WEI MIN 3 62.7% +67.9%
ZEMAN, ROBERT A 2 54.2% +27.9%
JOHNSON, EMILY KATHARINE 2 87.5% +21.9%
BOWERS, ERIN M 2 54.7% +9.8%
JOHNSON, DANIELLE D 2 45.0% +13.2%
NICOL, ALEXANDER W 2 42.7% +43.6%
RICCI, CRAIG D 1 53.7% +52.6%
WHALEY, PABLO S 1 25.0% +21.3%
SASTRI, SATYA B 1 62.6% +29.4%
JARRETT, SCOTT L 1 51.8% +46.6%

Hard Cases (61)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18573774 Photon Detector System with Distance Control WILLIAMS, DON J 147d overdue
18239453 System for Connecting a Connecting Device, in Particular a Distractor, to a Bone LAWSON, MATTHEW JAMES 120d overdue
17920723 LIQUID SULFONYLUREA HERBICIDE COMPOSITION STEINKE, SEAN JAMES 112d overdue
18039378 Methods of Producing Cured CO2 Sequestering Solid Compositions, Systems for Practicing the Same and Cured CO2 Sequestering Solid Compositions Produced Therefrom WEISS, PAMELA HL 79d overdue
18299317 AGROCHEMICAL COMPOSITION JOHNSON, DANIELLE D 72d overdue
17619569 ULTRAMODULAR IGG3-BASED SPACER DOMAIN AND MULTI-FUNCTION SITE FOR IMPLEMENTATION IN CHIMERIC ANTIGEN RECEPTOR DESIGN MIDDLETON, DANAYA L 28d overdue
19104933 Information Processing Method, Information Processing System, and Computer Readable Medium SHELDEN, BION A 24d overdue
18283757 A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF THE CERVICAL MUCUS BARRIER PROPERTIES OLSON, ANDREA STEFFEL 23d overdue

Interview Candidates (15)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18299317 AGROCHEMICAL COMPOSITION JOHNSON, DANIELLE D 72d overdue
18021387 MODIFIED LYMPHOCYTES NICOL, ALEXANDER W 19d overdue
17980848 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same LU, FRANK WEI MIN 17d overdue
17416266 AGROCHEMICAL COMPOSITION JOHNSON, DANIELLE D 3d overdue
18685782 Crown Rot Resistance JOHNSON, EMILY KATHARINE 19d
17955938 Methods of Depleting a Target Molecule from an Initial Collection of Nucleic Acids, and Compositions and Kits for Practicing the Same LU, FRANK WEI MIN 20d
19417018 SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY RICCI, CRAIG D —
19390421 COMPUTING ARCHITECTURE FOR COMPONENT-LEVEL PROGRESSION ASSESSMENT IN COMPOSITE ENTITIES WHALEY, PABLO S —

Client Portfolio (73 clients)

View all 73 →

Top Art Units

Art UnitApps
16834
16344
16744
16934
16623
17983
16533
16133
16813
16112

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19417018 SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY Allergan, Inc. RICCI, CRAIG D 1611 §102DP Non-Final OA — Pending Dec 11, 2025
19390421 COMPUTING ARCHITECTURE FOR COMPONENT-LEVEL PROGRESSION ASSESSMENT IN COMPOSITE ENTITIES Generation Lab, Inc. WHALEY, PABLO S 3619 §101§112 Final Rejection — Pending Nov 14, 2025
19363300 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same Takara Bio Usa, Inc. LU, FRANK WEI MIN 1683 §103 Final Rejection — Pending Oct 20, 2025
19286122 METHOD FOR PRODUCING LOW MOLECULAR WEIGHT POLYTETRAFLUOROETHYLENE (PTFE), LOW MOLECULAR WEIGHT PTFE AND COMPOSITION Guarniflon S.p.A. SASTRI, SATYA B 1762 §103§112DP Non-Final OA — Pending Jul 30, 2025
19213610 Pharmaceutical Composition for Preventing or Treating Sjogren's Syndrome Comprising Anti-SEMA4D Blocking Antibody as Active Ingredient Sialbio Co., Ltd. ZEMAN, ROBERT A 1645 §101§102§103§112 Non-Final OA — Pending May 20, 2025
19169584 METHOD FOR PREPARING FOR HARVESTING OF FOREST USING AN UN-MANNED VEHICLE AND UN-MANNED VEHICLE AND SYSTEM USING SAID METHOD Deep Forestry AB JARRETT, SCOTT L 3625 §101§103§112DP Non-Final OA — Pending Apr 03, 2025
19115426 Absorption Induced Caloric Effects and Uses Thereof Cambridge Enterprise Limited VAZQUEZ, ANA M 3763 §102§103§112 Non-Final OA — Pending Mar 26, 2025
19109930 Method for User Guidance for a Process Change, Computer Program Product and System Windmöller & Hölscher Kg ZERVOS, NIKOLAOS PHILLIP 2117 §101§102§103§112 Non-Final OA — Pending Mar 07, 2025
19104933 Information Processing Method, Information Processing System, and Computer Readable Medium The University of Osaka SHELDEN, BION A 3685 §101§102§112 Non-Final OA 24d overdue Pending Feb 19, 2025
19102345 METHOD FOR FIXING PRIMARY ANTIBODIES TO A BIOLOGICAL SAMPLE Pixelgen Technologies AB KIRWIN, STEFANIE JOHANNA 1677 §103§112 Non-Final OA 40d Pending Feb 07, 2025
19020424 Information Processing Method and Information Processing System Dongriii Co., Ltd. MOHAMMED, ASSAD 2691 §103 Non-Final OA — Pending Jan 14, 2025
18876445 Information Processing Method, Non-Transitory Computer-Readable Storage Medium and Information Processing Apparatus Socialgood, Inc. CHISM, STEVEN R 3689 §101§102§103 Non-Final OA — Pending Dec 18, 2024
18871951 Information Processing Method, Non-Transitory Computer-Readable Storage Medium, and Information Processing Apparatus Socialgood, Inc. JIMENEZ, JUSTIN ABEL 3697 §101§103 Final Rejection 12d Pending Dec 05, 2024
18871655 SAPONARIOSIDE BIOSYNTHETIC ENZYMES Plant Bioscience Limited JOHNSON, EMILY KATHARINE 1662 §103§112 Final Rejection — Pending Dec 04, 2024
18868649 Information Processing Method, Information Processing Device, and Recording Medium Exawizards Inc. MORRISON, JAY A 2151 §103 Non-Final OA — Pending Nov 22, 2024
18952849 NUTRITIONAL SUPPLEMENTS Laminaria Group AB WATTS, JENNA A 1791 §103Other Non-Final OA — Pending Nov 19, 2024
18866815 Storage Medium, Information Processing Method, and Information Processing Apparatus Nara Institute Of Science And Technology PEHLKE, CAROLYN A 3799 §102 Final Rejection 14d Pending Nov 18, 2024
18917854 NUTRITIONAL SUPPLEMENTS Laminaria Group AB LEBLANC, KATHERINE DEGUIRE §103 Non-Final OA — Pending Oct 16, 2024
18852156 Methods of Treating a Subject for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Compositions for Use in The Same Incelldx, Inc. BURKETT, DANIEL JOHN 1624 §102§103§112 Non-Final OA — Pending Sep 27, 2024
18896502 COMPOSITION FOR LOCALIZED FAT REDUCTION WITHOUT PAIN, EDEMA AND SIDE EFFECTS AND METHOD OF ADMINISTRATION THEREOF Ami Pharm Co., Ltd. SCHMIDT, IZABELA MARIA 1621 §103DP Non-Final OA — Pending Sep 25, 2024
18850852 Control Device, Control Method, Haptic Feedback System, and Program for Haptic Feedback Control Kurimoto, Ltd. PATEL, JITESH 2612 §103 Non-Final OA — Pending Sep 25, 2024
18839402 HIGH-CONTRAST EN-BLOC STAINING OF MOUSE WHOLE-BRAIN AND HUMAN BRAIN SAMPLES FOR EM-BASED CONNECTOMICS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. TIWARI, VYOMA SHUBHAM 1634 §112 Non-Final OA — Pending Aug 16, 2024
18802794 Vaginal Drug Delivery Device Ligalli B.V. MERCIER, MELISSA S 1615 §102§103§112 Non-Final OA — Pending Aug 13, 2024
18834867 Locking Device for Endoscope, Endoscope, and Locking Device Micro-Tech (Nanjing) Co., Ltd. CHOU, WILLIAM B 3795 §102 Non-Final OA — Pending Jul 31, 2024
18729118 HYBRID PHARMACEUTICAL COMPOSITION OBTAINED BY CONJUGATION OF A PROTON PUMP INHIBITOR AND A CARBON ANHYDRASE INHIBITOR Exo Lab Italia, S.r.l. NOTTINGHAM, KYLE GREGORY 1621 §101§112 Non-Final OA — Pending Jul 15, 2024
18753638 Blood Plasma Fractions for Use in Liver Regeneration Alkahest, Inc. KOSAR, AARON J 1655 §102DP Non-Final OA — Pending Jun 25, 2024
18743767 Methods and Compositions for Treating Fibroids Lundquist Institute For Biomedical Innovation AT Harbor-Ucla Medical Center AGGARWAL, SAHIL CHANDER 1623 §102§103§112 Non-Final OA — Pending Jun 14, 2024
18718324 Methods of Producing a Building Material Blue Planet Systems Corporation KUVAYSKAYA, ANASTASIA ALEKSEYEVNA 1731 §102§112 Non-Final OA — Pending Jun 10, 2024
18710784 Stretching Device and Method for Monoaxial Stretching of a Film Web in the Transport Direction Thereof Windmöller & Hölscher Kg ROBITAILLE, JOHN P 1743 §103 Final Rejection 29d Pending Jun 07, 2024
18667742 NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY Diamyd Medical AB ALSOMAIRY, SARAH ABDOALATIF 1646 §103§112DP Non-Final OA — Pending May 17, 2024
18706989 Fluidic Device With Capillary Barrier Purigen Biosystems, Inc. WRIGHT, PATRICIA KATHRYN 1798 §102§112 Non-Final OA — Pending May 02, 2024
18702286 SYSTEMS FOR THE EXTRACTION OF MACROMOLECULES Wuxi Biologics Ireland Limited SIEFKE, SAMUEL P 1758 §102 Non-Final OA — Pending Apr 17, 2024
18700474 System and Method/Process for In-Field Measurements of Plant Crops Agriculture Victoria Services Pty Ltd HELLNER, MARK 3645 §103§112 Non-Final OA — Pending Apr 11, 2024
18699071 Tumor Markers Ligalli B.V. DOUGHERTY, SEAN PATRICK 3791 §103§112 Final Rejection — Pending Apr 05, 2024
18624552 Armrest Swing Hinge Device Daechang Seat Co., Ltd. - Dongtan ACOSTA, ERIC LAZARUS 3644 §102§103 Final Rejection — Pending Apr 02, 2024
18695335 CELIAC DISEASE EPITOPES Nextera AS FAUST, AMBER KATHLEEN 1643 §101§102§103§112 Non-Final OA — Pending Mar 25, 2024
18694810 Blue Hydrogen Production Methods and Systems Blue Planet Systems Corporation HENDRICKSON, STUART L 1736 §102§103§112 Non-Final OA — Pending Mar 22, 2024
18691679 Electrostatic Spraying Device Arimitsu Industry Co., Ltd. KIM, CHRISTOPHER S 3752 §102§112 Final Rejection 14d Pending Mar 13, 2024
18601724 METHOD OF TREATING KNEE PAIN Orthotrophix, Inc. CARTER, SANDRA DILLAHUNT 1674 §103§112DP Non-Final OA — Pending Mar 11, 2024
18689636 Inference Device, Information Processing Method, and Recording Medium Anaut Inc. TSAI, TSUNG YIN 2656 §103 Non-Final OA 5d Pending Mar 06, 2024
18685782 Crown Rot Resistance Commonwealth Scientific And Industrial Research Organisation JOHNSON, EMILY KATHARINE 1662 §101§102§103§112 Final Rejection 19d Pending Feb 22, 2024
18292279 SYSTEM FOR EXPRESSION, PURIFICATION, AND DETECTION AND SCREENING OF BIOLOGICAL DRUGS Wuxi Biologics Ireland Limited GZYBOWSKI, MICHAEL STANLEY 1798 §102§103 Non-Final OA — Pending Jan 25, 2024
18291773 Methods and Compositions for Producing Cell-Source Identifiable Collections of Nucleic Acids Takara Bio Usa, Inc. GROSS, CHRISTOPHER M 1684 §102 Non-Final OA — Pending Jan 24, 2024
18404312 Submerged Arc Welding Method and Submerged Arc Welding Machine Daihen Corporation NGUYEN, PHUONG T 3761 §102§103§112 Non-Final OA — Pending Jan 04, 2024
18573774 Photon Detector System with Distance Control Single Quantum B.V. WILLIAMS, DON J 2878 §102§112 Non-Final OA 147d overdue Pending Dec 22, 2023
18392383 A Biomarker for Breast Cancer Diagnosis Using Estrogen in Exosomes and a Breast Cancer Diagnosis Kit Using the Biomarker Pusan National University Industry-University Cooperation Foundation KWAK, DEAN P 1795 §102§112Other Final Rejection — Pending Dec 21, 2023
18566579 PLASTIC DIGESTION Nbtech AB LANGEL, WAYNE A 1736 §102§103§112DP Final Rejection — Pending Dec 01, 2023
18519715 Device for Liquid Handling Takara Bio Usa, Inc. BERA, HENA RAKESHKUMAR 1798 §103 Final Rejection — Pending Nov 27, 2023
18560553 Method for Producing a Plastic Film from a Total Quantity of Raw Materials in a Film Extrusion Machine, and Computer Program Product for Carrying Out the Method Windmöller & Hölscher Kg WOLLSCHLAGER, JEFFREY MICHAEL 1742 §112 Non-Final OA — Pending Nov 13, 2023
18560551 Method for Producing Film from a Total Quantity of Raw Materials Using a Film Extrusion Machine, and Computer Program Product for Carrying Out the Method Windmöller & Hölscher Kg TAN, ALVIN H 2118 §103 Non-Final OA — Pending Nov 13, 2023

View all 109 →

Managing Pa - Bozicevic Field & Francis LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Pa - Bozicevic Field & Francis LLP's patent allowance rate?

75.8% of resolved applications prosecuted by Pa - Bozicevic Field & Francis LLP were allowed, across 8,797 applications in USPTO records.

How many office actions does Pa - Bozicevic Field & Francis LLP average before allowance?

3.96 office actions per allowed application on average.

How many pending office actions does Pa - Bozicevic Field & Francis LLP have?

109 pending office actions as of October 2026, for 73 clients, before 102 examiners in 71 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month